ロード中...
Novel and safe single-dose treatment of cutaneous leishmaniasis with implantable amphotericin B-loaded microparticles
The development of an effective amphotericin B (AmB) topical formulation to replace the systemically toxic injections currently used in cutaneous leishmaniasis (CL) treatment is challenging due to poor absorption through the skin. Aiming at an effective local chemotherapy, we designed PLGA (poly(lac...
保存先:
| 出版年: | Int J Parasitol Drugs Drug Resist |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6904829/ https://ncbi.nlm.nih.gov/pubmed/31331828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2019.06.001 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|